期刊文献+

乳腺癌原发灶和淋巴结转移灶MDR-1基因表达及临床分析 被引量:4

The Research on Relations between MDR-1 mRNA Expression and Clinical Pathological Features of Patients with Breast Cancer
下载PDF
导出
摘要 目的:初步探讨原发性乳腺癌原发灶和淋巴结转移灶MDR-1基因表达的情况,及其与临床病理因素的关系。方法:采用逆转录-多聚酶链反应(RT-PCR)技术,检测了30例原发性乳腺癌患者原发灶和淋巴结转移灶新鲜组织MDR-1基因表达水平。结果:原发灶MDR-1基因表达水平明显高于淋巴结转移灶,具有统计学意义。结论:原发灶基因表达高于转移灶,原发灶基因表达与年龄、TNM分期有关,而与肿块大小、淋巴结转移程度无关。 Objective: To probe the MDR-1 mRNA expression of primary tumor and metastatic lymph node of patients with breast cancer,and the relations between gene expression and clinical pathological features. Methods: The reverse Transcription-PCR technique was used to detect the MDR-1 mRNA expression of primary tumor and metastatic lymph nodes of 30 cases of patients with breast cancer, and the relations between gene expression and clinical pathological features were investigated. Results: The expression level of MDR-1 mRNA of primary tumor was significantly higher than that of metastatic lymph nodes. Conclusion: It was suggested that the positive rate of MDR-1 mRNA expression is higher in primary tumor than that of metastatic lymph node. MDR-1 mRNA expression in primary tumor is correlated with age and TNM staging, and it is not related to the size of tumor and extent of lymph node metastasis.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2004年第21期1221-1224,共4页 Chinese Journal of Clinical Oncology
基金 黑龙江省十五攻关项目课题基金资助(编号:20010101-00)
关键词 乳腺癌 原发灶 淋巴结转移灶MDR—1基因表达 RT—PCR Breast cancer Primary tumor Metastatic lymph node MDR-1 expression RT-PCR
  • 相关文献

参考文献10

  • 1潘启超,符立梧.我国对多药抗药性研究概况评述[J].广东医学,1998,19(5):321-323. 被引量:1
  • 2[2]Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in chinese hamster ovary cell mutants[J]. Biochem Biophys Acta, 1976,455(1):152~162
  • 3[3]Chen CJ, Chin JE, Ueda K, et al. Internal duplication and homology with bacterial transport proteins in the MDR-1 gene from MDR human cells[J]. Cell, 1986, 47(3):381~389
  • 4刘晓晴,石成华,宋三泰,张京生,徐建明,汤仲明,江泽飞.RT-PCR方法检测临床乳癌组织的多药耐药基因表达[J].中华肿瘤杂志,1996,18(4):263-265. 被引量:12
  • 5[5]Raaijmakers HGP, Izquierdo MAI, Lokhorst HM, et al. Lung-resistance related protein expression is anegative predictive factor for response to conventional low but not to intensified dose alkylating chemotherapy in multiple myeloma [J]. Blood, 1998, 91 (3):1029 ~ 1036
  • 6徐建明,宋三泰,刘晓晴,石成华,汤仲明,江泽飞,周丽,黄焰,张婧.乳腺癌多药抗药相关药物的体外敏感性与mdr-1基因表达[J].中华医学杂志,1997,77(5):371-373. 被引量:2
  • 7[7]Frei E Ⅲ, Antman K, Teicher B, et al. Bone marrow autotransplantatinon for solid tumors-prospects [J]. J Clin Oncol, 1989, 7(4):515~526
  • 8[8]Codman AJ, godie JH. Impact of dose-intense chemotherapy on the development of permanent drug resistance [J]. Semin Oncol,1987, 14(4 Suppl 4):29~33
  • 9[9]Peters WP, Ross M, Vredenburgh JJ, et al. High-dose chemotherapy and autlogous bone morrow support as consolidation after standard-dose adjuvant therapy for high risk prmiary breastcancer[J].J Clin Oncol, 1993, 11(6):1132~1143
  • 10[10]Venturini M, Mastro LD, Melioli G, et al. Release of peripheral blood stem cells during standard dose cyclophosphamide,epidoxorublcin 5-fluorouracil regimen plus granulocyte coony-stmiulating factor for breast cancer therapy[J]. Cancer, 1994, 74(8):2300~2306

二级参考文献30

共引文献12

同被引文献32

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部